Abstract
Evidence is accumulating about the role of individual AP-1 components in cell proliferation and transformation. Notably, Ras-mediated transformation is characterized by the upregulation of particular AP-1 members, such as c-Jun and Fra-1. The p14/p19ARF tumor suppressor gene is a key link between oncogenic Ras signaling and the p53 pathway. We explored the involvement of AP-1 dimers in the transcriptional regulation of the p14/p19ARF gene. We demonstrate that both the human and mouse ARF promoters are transcriptional targets of selective AP-1 dimers. The ARF promoter is regulated specifically by AP-1 heterodimers containing Fra-1. Overexpression of c-Junā¼Fra-1 dimers in primary murine fibroblast cells led to the upregulation of the endogenous ARF protein and growth arrest. Conversely, inhibition of c-Jun or Fra-1 protein levels resulted in decreased ARF expression. In addition, we show that AP-1 dimers cooperate with oncogenic Ras in the transcriptional activation of the p14/p19ARF promoter. Thus, AP-1 heterodimers may contribute to the regulation of ARF expression upon oncogenic signaling.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ameyar M, Atfi A, Cai Z, Stancou R, Shatrov V, Bettaieb A and Chouaib S . (1998). J. Biol. Chem., 273, 29002ā29008.
Ameyar M, Wisniewska M and Weitzman JB . (2003). Biochimie, 85, 747ā752.
Angel P and Karin M . (1991). Biochim. Biophys. Acta, 1072, 129ā157.
Bakiri L, Lallemand D, Bossy-Wetzel E and Yaniv M . (2000). EMBO J., 19, 2056ā2068.
Bakiri L, Matsuo K, Wisniewska M, Wagner EF and Yaniv M . (2002). Mol. Cell. Biol., 22, 4952ā4964.
Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL and Vousden KH . (1998). Nature, 395, 124ā125.
Behrens A, Jochum W, Sibilia M and Wagner EF . (2000). Oncogene, 19, 2657ā2663.
Berkovich E, Lamed Y and Ginsberg D . (2003). Cell. Cycle, 2, 127ā133.
Bos JL, Wolthuis RM, Zwartkruis F and Moen TC . (1989). Cancer Res., 49, 4682ā4689.
Brookes S, Rowe J, Ruas M, Llanos S, Clark PA, Lomax M, James MC, Vatcheva R, Bates S, Vousden KH, Parry D, Gruis N, Smit N, Bergman W and Peters G . (2002). EMBO J., 21, 2936ā2945.
Dignam JD, Lebovitz RM and Roeder RG . (1983). Nucleic Acids Res., 11, 1475ā1489.
Drayton S, Rowe J, Jones R, Vatcheva R, Cuthbert-Heavens D, Marshall J, Fried M and Peters G . (2003). Cancer Cell, 4, 301ā310.
Eferl R, Ricci R, Kenner L, Zenz R, David JP, Rath M and Wagner EF . (2003). Cell, 112, 181ā192.
Fleischmann A, Jochum W, Eferl R, Witowsky J and Wagner EF . (2003). Cancer Cell, 4, 477ā482.
Inoue K, Roussel MF and Sherr CJ . (1999). Proc. Natl. Acad. Sci. USA, 96, 3993ā3998.
Itahana K, Bhat KP, Jin A, Itahana Y, Hawke D, Kobayashi R and Zhang Y . (2003). Mol. Cell, 12, 1151ā1164.
Jacobs JJ, Kieboom K, Marino S, DePinho RA and van Lohuizen M . (1999). Nature, 397, 164ā168.
Jochum W, David JP, Elliott C, Wutz A, Plenk Jr H, Matsuo K and Wagner EF . (2000). Nat. Med., 6, 980ā984.
Jochum W, Passegue E and Wagner EF . (2001). Oncogene, 20, 2401ā2412.
Johnson R, Spiegelman B, Hanahan D and Wisdom R . (1996). Mol. Cell. Biol., 16, 4504ā4511.
Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF and Sherr CJ . (1998). Proc. Natl. Acad. Sci. USA, 95, 8292ā8297.
Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G and Sherr CJ . (1997). Cell, 91, 649ā659.
Korgaonkar C, Zhao L, Modestou M and Quelle DE . (2002). Mol. Cell. Biol., 22, 196ā206.
Krimpenfort P, Quon KC, Mooi WJ, Loonstra A and Berns A . (2001). Nature, 413, 83ā86.
Kuo ML, Duncavage EJ, Mathew R, den Besten W, Pei D, Naeve D, Yamamoto T, Cheng C, Sherr CJ and Roussel MF . (2003). Cancer Res., 63, 1046ā1053.
Lallemand D, Spyrou G, Yaniv M and Pfarr CM . (1997). Oncogene, 14, 819ā830.
Llanos S, Clark PA, Rowe J and Peters G . (2001). Nat. Cell Biol., 3, 445ā452.
Lowe SW and Sherr CJ . (2003). Curr. Opin. Genet. Dev., 13, 77ā83.
Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L, Doglioni C, Beach DH and Hannon GJ . (1999). Genes Dev., 13, 2207ā2217.
Mechta F, Lallemand D, Pfarr CM and Yaniv M . (1997). Oncogene, 14, 837ā847.
Mechta-Grigoriou F, Gerald D and Yaniv M . (2001). Oncogene, 20, 2378ā2389.
Modestou M, Puig-Antich V, Korgaonkar C, Eapen A and Quelle DE . (2001). Cancer Res., 61, 3145ā3150.
Palmero I, Murga M, Zubiaga A and Serrano M . (2002). Oncogene, 21, 2939ā2947.
Palmero I, Pantoja C and Serrano M . (1998). Nature, 395, 125ā126.
Pantoja C and Serrano M . (1999). Oncogene, 18, 4974ā4982.
Parisi T, Pollice A, Di Cristofano A, Calabro V, La Mantia G, Karayan L, Riou JF, Seite P, Migeon J, Cantereau A, Larsen CJ, Dimri GP, Itahana K, Acosta M and Campisi J . (2002). Biochem. Biophys. Res. Commun., 291, 1138ā1145.
Passegue E and Wagner EF . (2000). EMBO J., 19, 2969ā2979.
Pfarr CM, Mechta F, Spyrou G, Lallemand D, Carillo S and Yaniv M . (1994). Cell, 76, 747ā760.
Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C and DePinho RA . (1998). Cell, 92, 713ā723.
Quelle DE, Zindy F, Ashmun RA and Sherr CJ . (1995). Cell, 83, 993ā1000.
Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T, McMahon M, Oren M and McCormick F . (2000). Cell, 103, 321ā330.
Robertson KD and Jones PA . (1998). Mol. Cell. Biol., 18, 6457ā6473.
Rocha S, Campbell KJ and Perkins ND . (2003). Mol. Cell, 12, 15ā25.
Rowland BD, Denissov SG, Douma S, Stunnenberg HG, Bernards R and Peeper DS . (2002). Cancer Cell, 2, 55ā65.
Schutte J, Minna JD and Birrer MJ . (1989). Proc. Natl. Acad. Sci. USA, 86, 2257ā2261.
Serrano M . (2000). Carcinogenesis, 21, 865ā869.
Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D and DePinho RA . (1996). Cell, 85, 27ā37.
Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW and DePinho RA . (2001). Nature, 413, 86ā91.
Shaulian E, Schreiber M, Piu F, Beeche M, Wagner EF and Karin M . (2000). Cell, 103, 897ā907.
Sherr CJ . (2001). Nat. Rev. Mol. Cell. Biol., 2, 731ā737.
Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH and Peters G . (1998). EMBO J., 17, 5001ā5014.
Sugimoto M, Kuo ML, Roussel MF and Sherr CJ . (2003). Mol. Cell, 11, 415ā424.
Szabowski A, Maas-Szabowski N, Andrecht S, Kolbus A, Schorpp-Kistner M, Fusenig NE and Angel P . (2000). Cell, 103, 745ā755.
Tao W and Levine AJ . (1999). Proc. Natl. Acad. Sci. USA, 96, 6937ā6941.
Thierry F, Heard JM, Dartmann K and Yaniv M . (1987). J. Virol., 61, 134ā142.
Vallone D, Battista S, Pierantoni GM, Fedele M, Casalino L, Santoro M, Viglietto G, Fusco A and Verde P . (1997). EMBO J., 16, 5310ā5321.
van Dam H and Castellazzi M . (2001). Oncogene, 20, 2453ā2464.
Weber JD, Jeffers JR, Rehg JE, Randle DH, Lozano G, Roussel MF, Sherr CJ and Zambetti GP . (2000). Genes Dev., 14, 2358ā2365.
Weber JD, Taylor LJ, Roussel MF, Sherr CJ and Bar-Sagi D . (1999). Nat. Cell Biol., 1, 20ā26.
Weitzman JB, Fiette L, Matsuo K and Yaniv M . (2000). Mol. Cell, 6, 1109ā1119.
Young MR, Nair R, Bucheimer N, Tulsian P, Brown N, Chapp C, Hsu TC and Colburn NH . (2002). Mol. Cell. Biol., 22, 587ā598.
Acknowledgements
We are grateful to P Jones, C Sherr, D Ginsberg and G Langsley for providing reagents. We thank M Pontoglio, S Ait-Si-Ali and L Casalino for helpful discussions and advice. This work was supported by grants from the EC Biomed and Training and Mobility Programs, the Pasteur-Weizmann Foundation and the Association for International Cancer Research (AICR). MAZ was supported by the Ligue contre le Cancer, the Pasteur Institute and AICR. MW was supported by La Fondation pour la Recherche MĆ©dicale (FRM). LB was supported by an EMBO fellowship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ameyar-Zazoua, M., Wisniewska, M., Bakiri, L. et al. AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene. Oncogene 24, 2298ā2306 (2005). https://doi.org/10.1038/sj.onc.1208424
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208424
Keywords
This article is cited by
-
p53 loss does not permit escape from BrafV600E-induced senescence in a mouse model of lung cancer
Oncogene (2017)
-
Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers
Nature Communications (2016)
-
Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies
Cancer and Metastasis Reviews (2015)
-
INMAP, a novel truncated version of POLR3B, represses AP-1 and p53 transcriptional activity
Molecular and Cellular Biochemistry (2013)
-
Emerging roles of ATF2 and the dynamic AP1 network in cancer
Nature Reviews Cancer (2010)